Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle Grant Type Focus Area Country Application Due Date Optimizing Antimicrobial Stewardship (AMS) Interventions and Outcomes in Clinical Outcomes, Optimal Use and Resource UtilizatioRelease Date:Research Inflammation & Immunology China Optimizing Disease Management to Improve Alopecia Areata Quality of CareRelease Date:Quality Improvement Inflammation & Immunology China Research on Exploring Disease Assessment and Prioritizing Systematic Treatment for VitiligoRelease Date:Research Inflammation & Immunology China Quality Improvement in Molecular Testing Pathways for Metastatic Colorectal Cancer (mCRC)Release Date:Partner: American Society for Clinical Pathology (ASCP)Quality Improvement Oncology USA Personalized monitoring&treatment for HR+, HER2- mBC patients treated w CDK4/6i: incorporating Patient complexity risk factorsRelease Date:Quality Improvement, Research Oncology Italy Providing Appropriate Medical Care for IBD PatientsRelease Date:Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)Quality Improvement Inflammation & Immunology Japan Administration of brentuximab vedotin alone or in combination with other approved agents in pre and/or peri CAR-TRelease Date:Research Oncology USA Fostering Educational Initiatives for ALK+ Metastatic Non-Small Cell Lung Cancer(mNSCLC) Tyrosine Kinase Inhibitors(TKI) TherapyRelease Date:Education Oncology Canada Title Grant Type Focus Area Country Application Due Date 2021 Ulcerative Colitis Competitive Grant ProgramRelease Date:Research Inflammation & Immunology USA Adoption of Biosimilars in OncologyRelease Date:Quality Improvement Oncology Canada 2021 Global Hemophilia ASPIRERelease Date:Research Rare Disease All Inflammatory and Immune-Mediated Dermatologic DisordersRelease Date:Research Inflammation & Immunology USA Advances in Atopic Dermatitis & Alopecia Areata for Community Pharmacists & Managed Care Health Care ProfessionalsRelease Date:Education Inflammation & Immunology USA Understanding Residual Cardiovascular Risk Related to Triglyceride-Rich Remnant LipoproteinsRelease Date:Education Internal Medicine All Call for Independent Medical Education Grant Applications Oncology – Prostate CancerEducation Oncology USA I&I REALE 2021 RhEumatoid Arthritis Italian ReaL World ExperienceRelease Date:Research Inflammation & Immunology Italy 2021 Inflammatory Bowel Disease (IBD) FellowshipRelease Date:Fellowship Inflammation & Immunology USA Inflammatory and Immune-Mediated Dermatologic Disorders (Global excluding U.S.)Release Date:Research Inflammation & Immunology All 2021 Rheumatology FellowshipRelease Date:Fellowship Inflammation & Immunology USA 2021 Fellowship for Inflammatory Dermatological DiseasesRelease Date:Fellowship Inflammation & Immunology USA